Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
What is the purpose of this trial?
The proposed randomized, double-blind research study will use functional magnetic resonance neuroimaging using state-of-the-art HCP acquisition protocols and analytic pipelines, to identify predictors and correlates of response to an accepted first-line pharmacological treatment for obsessive-compulsive disorder.
We need both 40 matched Healthy controls for a single fMRI, as well as 80 Unmedicated participants with OCD for a randomized, double blind OCD treatment trial with 4 fMRI scans over 18 weeks.Please email OCD.Research@yale.edu or call and leave a message at 1-855-OCD-YALE (1-855-623-9253).
- Trial withYale University School of Medicine
- Ages18 years - 65 years
- Last Updated08/11/2023
- Study HIC#2000023688